# Protective Role of Vitamins C, D, and K in the Management of Dengue: A Narrative Review to Combat the Dengue Outbreak

**Authors:** Shah Md Muztahid Hasan Chowdhury, Md. Shafiul Hossen, Mohammad A. Rashid, Mahammed Shafin Ul Islam, Arafat Miah, Mohammed Safiqul Islam, Md. Abdul Barek

PMC · DOI: 10.1002/hsr2.71823 · Health Science Reports · 2026-02-17

## TL;DR

This paper reviews how vitamins C, D, and K may help manage dengue by reducing inflammation, supporting immunity, and preventing complications.

## Contribution

The paper highlights the combined protective roles of vitamins C, D, and K in dengue treatment through their anti-inflammatory and immunomodulatory effects.

## Key findings

- Vitamin C reduces oxidative damage and inflammation while supporting immune cell activity in dengue.
- Vitamin D limits viral replication and modulates immune responses in dengue-infected individuals.
- Vitamin K helps prevent complications like hepatic failure and reduces the need for blood transfusions in dengue.

## Abstract

Dengue fever is mostly found in tropical and subtropical regions and is spread by mosquitoes. Still now, no specific antiviral medication is available against the disease. However, several vitamins have been identified as potential dengue therapy supplements. Therefore, this study aimed to comprehensively gather data on the protective role of vitamins C, D, and K in the treatment of dengue fever.

To conduct the present narrative review, we retrieved data from Google Scholar, Web of Science, PubMed, Cochrane Library, BanglaJOL, Embase, and Scopus regarding the influence of vitamin supplements in dengue treatment. Articles published in English before March 2025 were included in the study.

This review explored how vitamin C neutralizes reactive oxygen species and reduces inflammation and oxidative damage in dengue infection. It stimulates chemotaxis and NK cell activity and controls the activities of monocytes, macrophages, phagocytosis, and the release of cytokines that promote inflammation. While shielding neutrophils from oxidative damage, it also promotes ROS production, which is essential for pathogen removal. Additionally, vitamin D possesses antiviral and immunomodulatory properties that help to fight dengue virus (DENV). It regulates the course of the disease in DENV‐infected individuals by modifying immunological responses. It can limit viral replication, decrease the expression of DENV entry receptors, and alter the expression of inflammatory cytokines in cells infected with the virus. Moreover, vitamin K is recommended in cases of dengue‐related hepatic failure and encephalopathy. The administration of vitamin K in early dengue hemorrhagic fever (DHF) may help to avoid anemia and lessen the need for transfusions.

By targeting important pathogenic processes, the adjunctive use of vitamins C, D, and K together provides an effective supplemental strategy in the dengue management and provides a good patient outcome in future dengue outbreak.

## Linked entities

- **Chemicals:** vitamin C (PubChem CID 54670067), vitamin K (PubChem CID 5280483)
- **Diseases:** dengue (MONDO:0005502), dengue fever (MONDO:0005502), encephalopathy (MONDO:0005560), dengue hemorrhagic fever (MONDO:0005358)

## Full-text entities

- **Genes:** MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, CALM1 (calmodulin 1) [NCBI Gene 801] {aka CALML2, CAM2, CAM3, CAMB, CAMC, CAMI}, MCOLN3 (mucolipin TRP cation channel 3) [NCBI Gene 55283] {aka TRP-ML3, TRPML3}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TLR9 (toll like receptor 9) [NCBI Gene 54106] {aka CD289}, TLR3 (toll like receptor 3) [NCBI Gene 7098] {aka CD283, IIAE2, IMD83}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, RXRA (retinoid X receptor alpha) [NCBI Gene 6256] {aka NR2B1, RXR-alpha, RXRalpha}, PLAT (plasminogen activator, tissue type) [NCBI Gene 5327] {aka T-PA, TPA}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, CISH (cytokine inducible SH2 containing protein) [NCBI Gene 1154] {aka BACTS2, CIS, CIS-1, G18, SOCS}, PDIA3 (protein disulfide isomerase family A member 3) [NCBI Gene 2923] {aka ER60, ERp57, ERp60, ERp61, GRP57, GRP58}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}
- **Diseases:** Bleeding (MESH:D006470), obese (MESH:D009765), organ failure (MESH:D009102), DENV (MESH:D003715), hematemesis (MESH:D006396), rash (MESH:D005076), pneumonia (MESH:D011014), VDD (MESH:D014808), viremia (MESH:D014766), epistaxis (MESH:D004844), diabetes (MESH:D003920), lung pathology (MESH:D008171), endothelial dysfunction (MESH:D014652), vasculopathy (MESH:D000090122), platelet dysfunction (MESH:D001791), DHF (MESH:D019595), hepatic dysfunction (MESH:D008107), headache (MESH:D006261), Inflammatory (MESH:D007249), shock (MESH:D012769), plasma leakage (MESH:D003763), skin bleeding (MESH:D012871), hematuria (MESH:D006417), influenza (MESH:D007251), PT (MESH:D007020), -related (MESH:D019973), gingival bleeding (MESH:D005884), tissue injury (MESH:D017695), consumptive coagulopathy (MESH:D004211), Contagious diseases (MESH:D011002), hepatic failure (MESH:D017093), hepatic injury (MESH:D056486), Thrombocytopenia (MESH:D013921), immunological dysregulation (MESH:D007154), Infection (MESH:D007239), abnormal coagulation (MESH:D001778), endothelial injury (MESH:D057772), herpes simplex virus (MESH:D006561), anemia (MESH:D000740), melena (MESH:D008551), dengue viral infections (MESH:D014777), G6PD deficiency (MESH:D005955), malnourished (MESH:D044342), hypertension (MESH:D006973), encephalopathy (MESH:D001927), hematological abnormalities (MESH:D006402)
- **Chemicals:** Vitamin C (MESH:D001205), norepinephrine (MESH:D009638), nitric oxide (MESH:D009569), tyrosine (MESH:D014443), aspirin (MESH:D001241), PGE2 (MESH:D015232), iron (MESH:D007501), oxalate (MESH:D010070), Vitamin D (MESH:D014807), histamine (MESH:D006632), singlet oxygen (MESH:D026082), oxygen (MESH:D010100), hydrogen (MESH:D006859), dopamine (MESH:D004298), calcium (MESH:D002118), ROS (MESH:D017382), alpha-tocopherol (MESH:D024502), lipid (MESH:D008055), vitamin K1 (MESH:D010837), Vitamin K (MESH:D014812), tocopherol (MESH:D024505), Antioxidant Role (-), 25-hydroxy vitamin D3 (MESH:D002112), carnitine (MESH:D002331)
- **Species:** Venezuelan equine encephalitis virus (no rank) [taxon 11036], Mus musculus (house mouse, species) [taxon 10090], Dengue virus (no rank) [taxon 12637], Homo sapiens (human, species) [taxon 9606], Aedes (subgenus) [taxon 149531]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12914079/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12914079/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12914079/full.md

---
Source: https://tomesphere.com/paper/PMC12914079